Literature DB >> 23256052

Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.

Yi-Xiang J Wang1.   

Abstract

Superparamagnetic iron oxide (SPIO) MR contrast agents are composed of nano-sized iron oxide crystals coated with dextran or carboxydextran. Two SPIO agents are clinically approved, namely: ferumoxides (Feridex in the USA, Endorem in Europe) with a particle size of 120 to 180 nm, and ferucarbotran (Resovist) with a particle size of about 60 nm. The principal effect of the SPIO particles is on T2* relaxation and thus MR imaging is usually performed using T2/T2*-weighted sequences in which the tissue signal loss is due to the susceptibility effects of the iron oxide core. Enhancement on T1-weighted images can also be seen with the smaller Resovist. Both Feridex and Resovist are approved specifically for MRI of the liver. The difference being that Resovist can be administered as a rapid bolus (and thus can be used with both dynamic and delayed imaging), whereas Feridex needs to be administered as a slow infusion and is used solely in delayed phase imaging. In the liver, these particles are sequestered by phagocytic Kupffer cells in normal reticuloendothelial system (RES), but are not retained in lesions lacking Kupffer cells. Consequently, there are significant differences in T2/T2* relaxation between normal tissue and lesions, resulting in increased lesion conspicuity and detectability. SPIO substantially increase the detectability of hepatic metastases. For focal hepatocellular lesions, SPIO-enhanced MR imaging exhibits slightly better diagnostic performance than dynamic CT. A combination of dynamic and static MR imaging technique using T1- and T2 imaging criteria appears to provide clinically more useful patterns of enhancement. Feridex and Resovist are also used for evaluating macrophage activities in some inflammatory lesions, but their clinical values remain to be further confirmed. The clinical development of Ferumoxtran (Combidex in the USA, Sinerem in Europe), designed for lymph node metastasis evaluation, is currently stopped.

Entities:  

Keywords:  Contrast media; Hepatocellular carcinoma; Liver; MRI; Neoplasm; SPIO; iron oxide

Year:  2011        PMID: 23256052      PMCID: PMC3496483          DOI: 10.3978/j.issn.2223-4292.2011.08.03

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  28 in total

1.  Perfusion MR imaging with a superparamagnetic iron oxide using T2-weighted and susceptibility-sensitive echoplanar sequences: evaluation of tumor vascularity in hepatocellular carcinoma.

Authors:  T Ichikawa; A S Arbab; T Araki; K Touyama; H Haradome; J Hachiya; M Yamaguchi; H Kumagai; S Aoki
Journal:  AJR Am J Roentgenol       Date:  1999-07       Impact factor: 3.959

2.  Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.

Authors:  Y Tang; Y Yamashita; A Arakawa; T Namimoto; K Mitsuzaki; Y Abe; K Katahira; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1999-06       Impact factor: 3.959

3.  Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

Authors:  Seong Hyun Kim; Dongil Choi; Seung Hoon Kim; Jae Hoon Lim; Won Jae Lee; Min Ju Kim; Hyo K Lim; Soon Jin Lee
Journal:  AJR Am J Roentgenol       Date:  2005-04       Impact factor: 3.959

4.  Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading.

Authors:  Y Imai; T Murakami; S Yoshida; M Nishikawa; M Ohsawa; K Tokunaga; M Murata; K Shibata; S Zushi; M Kurokawa; T Yonezawa; S Kawata; M Takamura; H Nagano; M Sakon; M Monden; K Wakasa; H Nakamura
Journal:  Hepatology       Date:  2000-08       Impact factor: 17.425

5.  Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis.

Authors:  J Ward; J A Guthrie; D J Scott; J Atchley; D Wilson; M H Davies; J I Wyatt; P J Robinson
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

6.  Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.

Authors:  P Reimer; N Jähnke; M Fiebich; W Schima; F Deckers; C Marx; N Holzknecht; S Saini
Journal:  Radiology       Date:  2000-10       Impact factor: 11.105

7.  Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging.

Authors:  M Oudkerk; A G van den Heuvel; P A Wielopolski; P I Schmitz; I H Borel Rinkes; T Wiggers
Journal:  Radiology       Date:  1997-05       Impact factor: 11.105

8.  Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours.

Authors:  E A Neuwelt; P Várallyay; A G Bagó; L L Muldoon; G Nesbit; R Nixon
Journal:  Neuropathol Appl Neurobiol       Date:  2004-10       Impact factor: 8.090

9.  Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver.

Authors:  M Tanaka; O Nakashima; Y Wada; M Kage; M Kojiro
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

10.  T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration--preliminary clinical experience with dynamic T1-weighted MR imaging.

Authors:  P Reimer; M Müller; C Marx; D Wiedermann; R Muller; E J Rummeny; W Ebert; K Shamsi; P E Peters
Journal:  Radiology       Date:  1998-12       Impact factor: 11.105

View more
  210 in total

1.  Exponential growth of publications on carbon nanodots by Chinese authors.

Authors:  Junqing Wang; Hak Soo Choi; Yì-Xiáng J Wáng
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

2.  Current status of superparamagnetic iron oxide contrast agents for liver magnetic resonance imaging.

Authors:  Yi-Xiang J Wang
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

Review 3.  Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.

Authors:  Houshang Amiri; Kolsoum Saeidi; Parvin Borhani; Arash Manafirad; Mahdi Ghavami; Valerio Zerbi
Journal:  ACS Chem Neurosci       Date:  2013-09-26       Impact factor: 4.418

4.  Cell Labeling with Magneto-Endosymbionts and the Dissection of the Subcellular Location, Fate, and Host Cell Interactions.

Authors:  Kayla R Lee; Abdul Wakeel; Papia Chakraborty; Chandler S Foote; Lauren Kajiura; Joyce C Barrozo; Andrea C Chan; Alexey V Bazarov; Ryan Spitler; Peter M Kutny; Jim M Denegre; Rob A Taft; Joachim Seemann; Bradley W Rice; Christopher H Contag; Brian K Rutt; Caleb B Bell
Journal:  Mol Imaging Biol       Date:  2018-02       Impact factor: 3.488

5.  Experimental challenges regarding the in vitro investigation of the nanoparticle-biocorona in disease states.

Authors:  Sherleen Xue-Fu Adamson; Zhoumeng Lin; Ran Chen; Lisa Kobos; Jonathan Shannahan
Journal:  Toxicol In Vitro       Date:  2018-05-05       Impact factor: 3.500

6.  A novel synthetic route for high-index faceted iron oxide concave nanocubes with high T2 relaxivity for in vivo MRI applications.

Authors:  Shu F Situ-Loewenstein; Sameera Wickramasinghe; Eric C Abenojar; Bernadette O Erokwu; Chris A Flask; Zhenghong Lee; Anna Cristina S Samia
Journal:  J Mater Sci Mater Med       Date:  2018-05-05       Impact factor: 3.896

7.  Targeted Superparamagnetic Iron Oxide Nanoparticles for In Vivo Magnetic Resonance Imaging of T-Cells in Rheumatoid Arthritis.

Authors:  Chih-Lung Chen; Tiing Yee Siow; Cheng-Hung Chou; Chen-Hsuan Lin; Ming-Huang Lin; Yung-Chu Chen; Wen-Yuan Hsieh; Shian-Jy Wang; Chen Chang
Journal:  Mol Imaging Biol       Date:  2017-04       Impact factor: 3.488

Review 8.  Magnetic particle imaging for radiation-free, sensitive and high-contrast vascular imaging and cell tracking.

Authors:  Xinyi Y Zhou; Zhi Wei Tay; Prashant Chandrasekharan; Elaine Y Yu; Daniel W Hensley; Ryan Orendorff; Kenneth E Jeffris; David Mai; Bo Zheng; Patrick W Goodwill; Steven M Conolly
Journal:  Curr Opin Chem Biol       Date:  2018-05-10       Impact factor: 8.822

9.  Carbon coated superparamagnetic iron oxide nanoparticles for sentinel lymph nodes mapping.

Authors:  Yi-Xiang J Wang; Da-Wei Wang; Xiao-Ming Zhu; Feng Zhao; Ken Cf Leung
Journal:  Quant Imaging Med Surg       Date:  2012-03

Review 10.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.